Literature DB >> 2437886

The development and characterization of monoclonal antibodies against rat cytomegalovirus induced antigens.

J H Bruning, W H Debie, P H Dormans, H Meijer, C A Bruggeman.   

Abstract

In this paper the development of a battery of approximately 70 mouse monoclonal antibodies (McAbs) to RCMV-induced antigens and their characterization is discussed. Their reactivity with the whole scala of ca. 30 virus specific proteins was tested in an enzyme linked immunoassay (ELISA) whereas their ability to detect RCMV-antigens at different locations of in vitro infected cell cultures and at different stages of infection was tested by immunofluorescence. In order to determine to what specific (viral) protein each of these McAbs is directed against we used an immunoprecipitation technique, followed by SDS-PAGE. Furthermore, neutralizing capacity of each McAb was tested, as well as the immunoglobulin class they belong to. In this manner we defined six categories of monoclonal antibodies on the basis of immunofluorescence aspect. The six categories identify most important viral structural proteins.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2437886     DOI: 10.1007/bf01313725

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  17 in total

1.  Monoclonal antibodies that recognize the P fimbriae F71, F72, F9, and F11 from uropathogenic Escherichia coli.

Authors:  J M de Ree; P Schwillens; J F van den Bosch
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

2.  Fluorescent antibodies and lectins stain intracellular structures in fixed cells treated with nonionic detergent.

Authors:  P Laurila; I Virtanen; J Wartiovaara; S Stenman
Journal:  J Histochem Cytochem       Date:  1978-04       Impact factor: 2.479

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  Plant virus serology.

Authors:  M H Van Regenmortel
Journal:  Adv Virus Res       Date:  1966       Impact factor: 9.937

5.  Isolation and characterization of monoclonal antibodies to structural and nonstructural herpesvirus saimiri proteins.

Authors:  R E Randall; C Newman; R W Honess
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

6.  Passive transfer of cytomegalovirus by cardiac and renal organ transplants in a rat model.

Authors:  J H Bruning; C A Bruggeman; C P van Boven; P J van Breda Vriesman
Journal:  Transplantation       Date:  1986-06       Impact factor: 4.939

7.  Isolation of a cytomegalovirus-like agent from wild rats.

Authors:  C A Bruggeman; H Meijer; P H Dormans; W M Debie; G E Grauls; C P van Boven
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

8.  Crossed immunoelectrophoretic studies of the solubility immunogenicity of herpes simplex virus antigens.

Authors:  B F Vestergaard; O J Bjerrum; B Norrild; P C Grauballe
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

9.  High degree of idiotypic cross-reactivity among murine monoclonal antibodies to thyroglobulin.

Authors:  M Zanetti; M De Baets; J Rogers
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

10.  Infection of laboratory rats with a new cytomegalo-like virus.

Authors:  C A Bruggeman; W M Debie; G Grauls; G Majoor; C P van Boven
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

View more
  10 in total

1.  Induction of vascular adhesion protein-1 during liver allograft rejection and concomitant cytomegalovirus infection in rats.

Authors:  T Martelius; M Salmi; H Wu; C Bruggeman; K Höckerstedt; S Jalkanen; I Lautenschlager
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Cytomegalovirus induced PMN adherence in relation to an ELAM-1 antigen present on infected endothelial cell monolayers.

Authors:  A H Span; W Mullers; A M Miltenburg; C A Bruggeman
Journal:  Immunology       Date:  1991-03       Impact factor: 7.397

3.  Comparative activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine against rat cytomegalovirus infection in vitro and in vivo.

Authors:  F S Stals; E de Clercq; C A Bruggeman
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

4.  Deletion of the R78 G protein-coupled receptor gene from rat cytomegalovirus results in an attenuated, syncytium-inducing mutant strain.

Authors:  P S Beisser; G Grauls; C A Bruggeman; C Vink
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

5.  An animal model for therapeutic intervention studies of CMV infection in the immunocompromised host.

Authors:  F S Stals; F Bosman; C P van Boven; C A Bruggeman
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

6.  The R33 G protein-coupled receptor gene of rat cytomegalovirus plays an essential role in the pathogenesis of viral infection.

Authors:  P S Beisser; C Vink; J G Van Dam; G Grauls; S J Vanherle; C A Bruggeman
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

7.  The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and nonatherosclerotic patients.

Authors:  M G Hendrix; P H Dormans; P Kitslaar; F Bosman; C A Bruggeman
Journal:  Am J Pathol       Date:  1989-05       Impact factor: 4.307

8.  Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?

Authors:  Mark R Schleiss
Journal:  Future Virol       Date:  2013-12       Impact factor: 1.831

9.  Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts.

Authors:  K B Lemström; J H Bruning; C A Bruggeman; I T Lautenschlager; P J Häyry
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

10.  Rat cytomegalovirus-induced pneumonitis after allogeneic bone marrow transplantation: effective treatment with (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine.

Authors:  F S Stals; A Zeytinoglu; M Havenith; E de Clercq; C A Bruggeman
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.